Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.

scientific article published on 10 June 2016

Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HON.2306
P698PubMed publication ID27283119

P50authorNathalie SteimbergQ43122105
Giovanna MazzoleniQ55860441
Luisa PascucciQ56250327
P2093author name stringValeria Sordi
Angiola Berenzi
Anna Benetti
Arianna Bonomi
Augusto Pessina
Giulio Alessandri
Valentina Coccè
Jennifer Boniotti
P2860cites workRapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Clinical use of proteasome inhibitors in the treatment of multiple myelomaQ28080999
Ex-vivo dynamic 3-D culture of human tissues in the RCCS™ bioreactor allows the study of Multiple Myeloma biology and response to therapyQ28535634
Advances in the understanding of myeloma bone disease and tumour growthQ33829022
Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapyQ34113542
Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growthQ34741694
Stem cell transplantation for multiple myelomaQ35692626
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthQ36092153
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.Q36733492
The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehiclesQ36842444
The pharmacological bases of the antiangiogenic activity of paclitaxelQ36927558
New therapies in multiple myeloma.Q36986576
Modelling tissues in 3D: the next future of pharmaco-toxicology and food research?Q37124172
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathwayQ37372102
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets.Q37484765
Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?Q37833578
Fibroblasts maintained in 3 dimensions show a better differentiation state and higher sensitivity to estrogensQ38961393
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug deliveryQ38969541
Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activityQ39094393
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticlesQ39445337
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer AgentsQ58828469
MRT Letter: 3D culture of isolated cells: A fast and efficient method for optimizing their histochemical and immunocytochemical analysesQ61386768
Structural analysis of rat bone explants kept in vitro in simulated microgravity conditionsQ61386796
P433issue4
P921main subjectmultiple myelomaQ467635
P304page(s)693-702
P577publication date2016-06-10
P1433published inHematological OncologyQ15762617
P1476titlePaclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system
P478volume35

Reverse relations

cites work (P2860)
Q572155223d Tissue Engineered In Vitro Models Of Cancer In Bone
Q91658925Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities
Q58760128Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth
Q52608756Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.
Q52679939Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T-cell immune responses via PD-1/PD-L1 pathway.
Q52591382Dental pulp stem cells used to deliver the anticancer drug paclitaxel.
Q92798740Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities
Q47821722Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery.
Q98466507Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
Q89976335Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications
Q92081475The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy

Search more.